ABSTRACT
All domains of life feature diverse molecular clock machineries that synchronize physiological processes to diurnal environmental fluctuations. However, no mechanisms are known to cross-regulate prokaryotic and eukaryotic circadian rhythms in multikingdom ecosystems. Here, we show that the intestinal microbiota, in both mice and humans, exhibits diurnal oscillations that are influenced by feeding rhythms, leading to time-specific compositional and functional profiles over the course of a day. Ablation of host molecular clock components or induction of jet lag leads to aberrant microbiota diurnal fluctuations and dysbiosis, driven by impaired feeding rhythmicity. Consequently, jet-lag-induced dysbiosis in both mice and humans promotes glucose intolerance and obesity that are transferrable to germ-free mice upon fecal transplantation. Together, these findings provide evidence of coordinated metaorganism diurnal rhythmicity and offer a microbiome-dependent mechanism for common metabolic disturbances in humans with aberrant circadian rhythms, such as those documented in shift workers and frequent flyers.
Subject(s)
Circadian Clocks , Circadian Rhythm , Glucose Intolerance , Microbiota , Animals , Dysbiosis/microbiology , Dysbiosis/physiopathology , Feeding Behavior , Homeostasis , Humans , Jet Lag Syndrome/physiopathology , Metabolic Diseases/microbiology , Metabolic Diseases/physiopathology , Mice , Obesity/metabolism , SleepABSTRACT
Mucus production by goblet cells of the large intestine serves as a crucial antimicrobial protective mechanism at the interface between the eukaryotic and prokaryotic cells of the mammalian intestinal ecosystem. However, the regulatory pathways involved in goblet cell-induced mucus secretion remain largely unknown. Here, we demonstrate that the NLRP6 inflammasome, a recently described regulator of colonic microbiota composition and biogeographical distribution, is a critical orchestrator of goblet cell mucin granule exocytosis. NLRP6 deficiency leads to defective autophagy in goblet cells and abrogated mucus secretion into the large intestinal lumen. Consequently, NLRP6 inflammasome-deficient mice are unable to clear enteric pathogens from the mucosal surface, rendering them highly susceptible to persistent infection. This study identifies an innate immune regulatory pathway governing goblet cell mucus secretion, linking nonhematopoietic inflammasome signaling to autophagy and highlighting the goblet cell as a critical innate immune player in the control of intestinal host-microbial mutualism. PAPERCLIP:
Subject(s)
Colon/immunology , Goblet Cells/immunology , Inflammasomes/immunology , Intestinal Mucosa/immunology , Receptors, Cell Surface/immunology , Animals , Autophagy , Colitis/immunology , Colitis/microbiology , Colon/microbiology , Epithelial Cells/immunology , Epithelial Cells/metabolism , Goblet Cells/cytology , Intestinal Mucosa/cytology , Intestinal Mucosa/metabolism , Mice , Mucus/metabolismABSTRACT
Obesity, diabetes, and related manifestations are associated with an enhanced, but poorly understood, risk for mucosal infection and systemic inflammation. Here, we show in mouse models of obesity and diabetes that hyperglycemia drives intestinal barrier permeability, through GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells and alteration of tight and adherence junction integrity. Consequently, hyperglycemia-mediated barrier disruption leads to systemic influx of microbial products and enhanced dissemination of enteric infection. Treatment of hyperglycemia, intestinal epithelial-specific GLUT2 deletion, or inhibition of glucose metabolism restores barrier function and bacterial containment. In humans, systemic influx of intestinal microbiome products correlates with individualized glycemic control, indicated by glycated hemoglobin levels. Together, our results mechanistically link hyperglycemia and intestinal barrier function with systemic infectious and inflammatory consequences of obesity and diabetes.
Subject(s)
Blood Glucose/metabolism , Diabetes Mellitus, Experimental/physiopathology , Escherichia coli Infections/physiopathology , Hyperglycemia/physiopathology , Intestinal Diseases/microbiology , Intestinal Diseases/physiopathology , Animals , Caco-2 Cells , Cellular Reprogramming , Citrobacter rodentium , Enteropathogenic Escherichia coli , Gastrointestinal Microbiome , Gene Deletion , Glucose/metabolism , Glucose/pharmacology , Glucose Transporter Type 2/genetics , Humans , Intestinal Mucosa/microbiology , Intestinal Mucosa/physiopathology , Mice , Mice, Inbred Strains , Obesity/physiopathology , Permeability , Receptors, Leptin/genetics , StreptozocinABSTRACT
Inflammasomes are multiprotein complexes that serve as signaling platforms initiating innate immune responses. These structures are assembled upon a large array of stimuli, sensing both microbial products and endogenous signals indicating loss of cellular homeostasis. As such, inflammasomes are regarded as sensors of cellular integrity and tissue health, which, upon disruption of homeostasis, provoke an inflammatory response by the release of potent cytokines. Recent evidence suggests that in addition to sensing cellular integrity, inflammasomes are involved in the homeostatic mutualism between the host and its indigenous microbiota. Here, we summarize the involvement of various inflammasomes in host-microbiota interactions and focus on the role of commensal as well as pathogenic bacteria in inflammasome signaling.